ELEVATE Study 410 Initial Results: Phase IV Study of Perampanel as Monotherapy or First Adjunctive Therapy in Patients Aged >= 4 Years with Epilepsy

EPILEPSIA(2021)

Cited 0|Views1
No score
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined